X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dual antiplatelet therapy (2034) 2034
humans (1236) 1236
cardiac & cardiovascular systems (1221) 1221
percutaneous coronary intervention (857) 857
clopidogrel (822) 822
male (610) 610
female (599) 599
aspirin (576) 576
aged (515) 515
drug-eluting stents (488) 488
middle aged (488) 488
treatment outcome (456) 456
thrombosis (451) 451
risk factors (440) 440
platelet aggregation inhibitors - therapeutic use (427) 427
stents (399) 399
myocardial-infarction (346) 346
acute coronary syndrome (334) 334
acute coronary syndromes (329) 329
platelet aggregation inhibitors - administration & dosage (329) 329
ticlopidine - analogs & derivatives (329) 329
drug therapy, combination (324) 324
bleeding (310) 310
abridged index medicus (306) 306
dual-antiplatelet therapy (306) 306
platelet aggregation inhibitors - adverse effects (298) 298
cardiology (286) 286
mortality (286) 286
acute myocardial-infarction (275) 275
peripheral vascular disease (274) 274
ticagrelor (273) 273
time factors (272) 272
myocardial infarction (266) 266
implantation (265) 265
coronary artery disease (262) 262
risk (254) 254
drug-eluting stent (253) 253
coronary heart disease (252) 252
outcomes (247) 247
stent (242) 242
artery-disease (237) 237
intervention (235) 235
care and treatment (231) 231
heart attacks (231) 231
stroke (227) 227
pharmacology & pharmacy (224) 224
cardiovascular disease (219) 219
cardiovascular (218) 218
patients (208) 208
medicine, general & internal (204) 204
cardiac patients (203) 203
elevation myocardial-infarction (202) 202
hemorrhage - chemically induced (202) 202
stent thrombosis (201) 201
percutaneous coronary intervention - adverse effects (190) 190
anticoagulants (189) 189
analysis (185) 185
risk assessment (182) 182
ticlopidine - therapeutic use (181) 181
transluminal angioplasty (176) 176
bare-metal stents (171) 171
double-blind (171) 171
prasugrel (166) 166
clinical-outcomes (165) 165
focused update (164) 164
prospective studies (164) 164
duration (162) 162
prevention (162) 162
aspirin - administration & dosage (159) 159
atrial fibrillation (159) 159
cardiovascular diseases (153) 153
eluting stent implantation (153) 153
aspirin - therapeutic use (152) 152
association task-force (151) 151
hematology (148) 148
management (148) 148
metaanalysis (148) 148
surgery (148) 148
impact (146) 146
aged, 80 and over (144) 144
ticlopidine - administration & dosage (143) 143
antiplatelet therapy (140) 140
coronary artery disease - therapy (140) 140
coronary vessels (137) 137
medicine & public health (134) 134
antithrombotic therapy (133) 133
atrial-fibrillation (132) 132
guidelines (132) 132
blood platelets (130) 130
retrospective studies (130) 130
efficacy (128) 128
follow-up studies (128) 128
angioplasty (127) 127
trial (127) 127
events (126) 126
drug therapy (124) 124
ischemia (124) 124
therapy (124) 124
acute coronary syndrome - drug therapy (122) 122
secondary prevention (122) 122
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2337) 2337
German (45) 45
Japanese (39) 39
Russian (25) 25
Spanish (18) 18
Polish (9) 9
French (8) 8
Czech (5) 5
Portuguese (3) 3
Turkish (2) 2
Chinese (1) 1
Dutch (1) 1
Italian (1) 1
Korean (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 04/2015, Volume 65, Issue 16, pp. 1619 - 1629
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e637S - e668S
Background: This guideline focuses on long-term administration of antithrombotic drugs designed for primary and secondary prevention of cardiovascular disease, including two new antiplatelet therapies. Methods... 
LONG-TERM | CHRONIC HEART-FAILURE | COST-EFFECTIVENESS | LEFT-VENTRICULAR THROMBUS | LOW-DOSE ASPIRIN | DUAL ANTIPLATELET THERAPY | ANTERIOR MYOCARDIAL-INFARCTION | RESPIRATORY SYSTEM | CLOPIDOGREL PLUS ASPIRIN | RANDOMIZED-TRIAL | ACUTE CORONARY SYNDROMES | CRITICAL CARE MEDICINE | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Long-Term Care | Secondary Prevention | Angioplasty, Balloon, Coronary | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Societies, Medical | Coronary Disease - complications | Fibrinolytic Agents - therapeutic use | Cardiovascular Diseases - blood | Thrombosis - blood | Thrombosis - prevention & control | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Stents | Platelet Aggregation Inhibitors - adverse effects | Coronary Disease - blood | Risk Factors | Myocardial Ischemia - blood | Combined Modality Therapy | Evidence-Based Medicine | Myocardial Ischemia - drug therapy | Myocardial Ischemia - complications | Coronary Disease - drug therapy | Aged | Thrombosis - drug therapy | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 10/2016, Volume 134, Issue 14, pp. 989 - 998
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 380, Issue 16, pp. 1509 - 1524
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2018, Volume 72, Issue 23, pp. 2886 - 2903
Journal Article
by Valgimigli, Marco and Bueno, Héctor and Byrne, Robert A and Collet, Jean-Philippe and Costa, Francesco and Jeppsson, Anders and Jüni, Peter and Kastrati, Adnan and Kolh, Philippe and Mauri, Laura and Montalescot, Gilles and Neumann, Franz-Josef and Petricevic, Mate and Roffi, Marco and Steg, Philippe Gabriel and Windecker, Stephan and Zamorano, Jose Luis and Levine, Glenn N and Badimon, Lina and Vranckx, Pascal and Agewall, Stefan and Andreotti, Felicita and Antman, Elliott and Barbato, Emanuele and Bassand, Jean-Pierre and Bugiardini, Raffaele and Cikirikcioglu, Mustafa and Cuisset, Thomas and De Bonis, Michele and Delgado, Victora and Fitzsimons, Donna and Gaemperli, Oliver and Galiè, Nazzareno and Gilard, Martine and Hamm, Christian W and Ibanez, Borja and Iung, Bernard and James, Stefan and Knuuti, Juhani and Landmesser, Ulf and Leclercq, Christophe and Lettino, Maddalena and Lip, Gregory and Piepoli, Massimo Francesco and Pierard, Luc and Schwerzmann, Markus and Sechtem, Udo and Simpson, Iain A and Uva, Miguel Sousa and Stabile, Eugenio and Storey, Robert F and Tendera, Michal and Van de Werf, Frans and Verheugt, Freek and Aboyans, Victor and Coca, Antonio and Coman, Ioan Mircea and Dean, Veronica and Delgado, Victoria and Hindricks, Gerhard and Katus, Hugo A and Lancellotti, Patrizio and McDonagh, Theresa and Ponikowski, Piotr and Richter, Dimitrios J and Shlyakhto, Evgeny and Roithinger, Franz Xaver and Aliyev, Farid and Stelmashok, Valeriy and Desmet, Walter and Postadzhiyan, Arman and Georghiou, Georgios P and Motovska, Zuzana and Grove, Erik Lerkevang and Marandi, Toomas and Kiviniemi, Tuomas and Kedev, Sasko and Massberg, Steffen and Alexopoulos, Dimitrios and Kiss, Robert Gabor and Gudmundsdottir, Ingibjorg Jona and McFadden, Eugène P and Lev, Eli and De Luca, Leonardo and Sugraliyev, Akhmetzhan and Haliti, Edmond and Mirrakhimov, Erkin and Latkovskis, Gustavs and Petrauskiene, Birute and Huijnen, Steve and Magri, Caroline Jane and Cherradi, Rhizlan and Ten Berg, Jurrien M and Eritsland, Jan and Budaj, Andrzej and Aguiar, Carlos Tavares and Duplyakov, Dmitry and Zavatta, Marco and Antonijevic, Nebojsa M and Fras, Zlatko and ... and ESC Committee for Practice Guidelines (CPG) and ESC Scientific Document Group and ESC National Cardiac Societies and European Asso Cardio-Thoracic Surg and Task Force Dual Antiplatelet Ther
European heart journal, ISSN 1522-9645, 2018, Volume 39, Issue 3, pp. 213 - 260
Journal Article
by Steg, Ph. Gabriel and James, Stefan K and Atar, Dan and Badano, Luigi P and Lundqvist, Carina Blomstrom and Borger, Michael A and Di Mario, Carlo and Dickstein, Kenneth and Ducrocq, Gregory and Fernandez-Aviles, Francisco and Gershlick, Anthony H and Giannuzzi, Pantaleo and Halvorsen, Sigrun and Huber, Kurt and Juni, Peter and Kastrati, Adnan and Knuuti, Juhani and Lenzen, Mattie J and Mahaffey, Kenneth W and Valgimigli, Marco and van't Hof, Arnoud and Widimsky, Petr and Zahger, Doron and Bax, Jeroen J and Baumgartner, Helmut and Ceconi, Claudio and Dean, Veronica and Deaton, Christi and Fagard, Robert and Funck-Brentano, Christian and Hasdai, David and Hoes, Arno and Kirchhof, Paulus and Kolh, Philippe and McDonagh, Theresa and Moulin, Cyril and Popescu, Bogdan A and Reiner, Željko and Sechtem, Udo and Sirnes, Per Anton and Tendera, Michal and Torbicki, Adam and Vahanian, Alec and Windecker, Stephan and Astin, Felicity and Åström-Olsson, Karin and Budaj, Andrzej and Clemmensen, Peter and Collet, Jean-Philippe and Fox, Keith A and Fuat, Ahmet and Gustiene, Olivija and Hamm, Christian W and Kala, Petr and Lancellotti, Patrizio and Maggioni, Aldo Pietro and Merkely, Béla and Neumann, Franz-Josef and Piepoli, Massimo F and Van de Werf, Frans and Verheugt, Freek and Wallentin, Lars and Authors Task Force Members and Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) and ESC Committee for Practice Guidelines (CPG) and Authors/Task Force Members and Document Reviewers
European heart journal, ISSN 1522-9645, 2012, Volume 33, Issue 20, pp. 2569 - 2619
Acute coronary syndromes Ischaemic heart disease | Reperfusion therapy | Primary percutaneous coronary intervention Antithrombotic therapy | Secondary prevention | Acute myocardial infarction | ST-segment elevation | Guidelines | CARDIAC & CARDIOVASCULAR SYSTEMS | BARE-METAL STENTS | Primary percutaneous coronary intervention | AMERICAN-HEART-ASSOCIATION | PERCUTANEOUS CORONARY INTERVENTION | INTRAAORTIC BALLOON COUNTERPULSATION | Antithrombotic therapy | LEFT-VENTRICULAR DYSFUNCTION | DUAL ANTIPLATELET THERAPY | SUSPECTED CARDIOGENIC-SHOCK | IN-HOSPITAL MORTALITY | Acute coronary syndromes | Ischaemic heart disease | CONVERTING-ENZYME INHIBITOR | DRUG-ELUTING STENTS | Antifibrinolytic Agents - therapeutic use | Humans | Heart Failure - physiopathology | Hyperglycemia - complications | Anxiety - prevention & control | Long-Term Care | Hemodynamics - physiology | Cardiomyopathies - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Myocardial Infarction - therapy | Out-of-Hospital Cardiac Arrest - therapy | Percutaneous Coronary Intervention - methods | Fibrinolytic Agents - therapeutic use | Electrocardiography | Cardiac Imaging Techniques - methods | Platelet Aggregation Inhibitors - therapeutic use | Dyspnea - prevention & control | Exercise Therapy - methods | Myocardial Infarction - diagnosis | Heart Failure - complications | Coronary Artery Bypass - methods | Arrhythmias, Cardiac - therapy | Pain - prevention & control | Risk Assessment | Risk Reduction Behavior | Time-to-Treatment | Emergency Treatment - methods | Biomedical Research - trends | Arrhythmias, Cardiac - etiology | Hospitalization | Out-of-Hospital Cardiac Arrest - diagnosis | Forecasting | Myocardial Reperfusion - methods | Cardiomyopathies - therapy | Myocardial Infarction - complications | Emergency Medical Services - organization & administration | General Practice - organization & administration | Hyperglycemia - therapy
Journal Article